Combined antihypertensive may not be as good as it looks for type 2 diabetesBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7619.536-a (Published 13 September 2007) Cite this as: BMJ 2007;335:536
A large international trial reports that a fixed combination of the angiotensin converting enzyme (ACE) inhibitor perindopril and the diuretic indapamide protects people with type 2 diabetes from cardiovascular disease and microvascular complications (combined hazard ratio 0.91, 95% CI 0.83 to 1.00, P=0.04) and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial